Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Resolution. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106947792A reveals enzymatic route for Lifitegrast intermediate. Delivers high purity and cost reduction in API intermediate manufacturing for global supply chains.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN109608344A details efficient chiral resolution for (R)-3-amino butanol. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Discover a novel dynamic resolution method for alpha-substituted-2-aminoacetamides achieving 98% yield. Ideal for pharmaceutical and agrochemical intermediate manufacturing.
Patent CN104830943A reveals enzymatic resolution for high-purity eldecalcitol intermediate, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturers.
Analyze patent CN103373931B for Dapoxetine production. Discover cost-effective, high-purity manufacturing routes suitable for commercial scale-up and supply chain optimization.
Novel patent CN104370769B enables robust production of Saxagliptin intermediates with improved purity and supply chain stability for global pharmaceutical partners.
Advanced chiral resolution process for S-(-)-Nadifloxacin. Enhances solubility and bioavailability. Cost-effective manufacturing for global pharmaceutical supply chains.
Novel preparation method for Voriconazole using optimized L(-)-camphor-10-sulfonic acid resolution. Reduces reagent consumption and simplifies purification for high-purity API manufacturing.
Novel enzymatic route for posaconazole intermediate improves yield and purity. Cost-effective manufacturing solution for antifungal API supply chains.
Patent CN104030996B details a novel Valsartan refining method ensuring high optical purity and yield. Discover cost-effective supply chain solutions for chiral API production.
Patent CN108192932B details a mild enzymatic route for chiral alcohols, offering high ee values and scalable production for pharmaceutical intermediates.
Patent CN113087691A details a Pd-catalyzed kinetic resolution for chiral aryl tertiary alcohols. Discover cost-effective routes for high-purity pharmaceutical intermediates.
Patent CN1027503C details a superior crystalline salt form of 4-(di-n-propyl)amino-6-aminocarbonyl-1,3,4,5-tetrahydrobenzo[cd]indole, offering enhanced purity and scalable manufacturing for CNS drug development.
Patent CN108473418A reveals a safer chiral resolution method for sulfonamide derivatives. Discover cost-effective manufacturing and reliable supply chain solutions for high-purity intermediates.
Discover efficient rhodium-catalyzed synthesis of planar chiral metallocenes. Enhance supply chain reliability and reduce manufacturing costs for high-purity intermediates.
Patent CN112266381B details a cost-effective synthesis of Barosavir intermediates using early resolution, offering significant supply chain advantages for API manufacturers.
Discover the optimized synthesis of S-clopidogrel bisulfate via catalytic sulfonylation. A reliable API intermediate supplier offering cost-effective, high-purity manufacturing solutions.
Advanced purification of 3-hydroxyamidinophenylalanine derivatives using aromatic sulfonic acids. Enhances yield and purity for pharmaceutical manufacturing.
Patent CN1199961C enables high-selectivity splitting of DL-pantoyl internal ester for D-calcium pantothenate production reducing costs and improving supply chain reliability significantly.